Nine cases per 100,000 population and 3.3 cases per 100,000 people, with an increasing trend year by year, especially among the middle‐aged and elderly. 43 Its overall survival is not optimistic, the 5‐year survival rate of newly diagnosed patients is about 47·3%−53·8%. 44 The treatment of MM has improved significantly over the past 20 years, with patients continuing to benefit from effective treatments with acceptable toxicity, such as the use of proteasome inhibitors.
← all excerpts
Biological research on the occurrence and development of multiple myeloma and its treatment.
1
—
—